Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1584-1592

  Georgiadou, Dimitra ^a   Hearn, Arron ^b   Evnouchidou, Irini ^a   Chroni, Angeliki ^a   Leondiadis, Leondios ^a   York, Ian A ^c   Rock, Kenneth L ^b   Stratikos, Efstratios ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Michigan State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CYTOSOL AMINOPEPTIDASE; ENDOPLASMIC RETICULUMAMINOPEPTIDASE 1; EPITOPE; INSULIN REGULATED AMINOPEPTIDASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; ANTIGEN; CYSTYL AMINOPEPTIDASE; ERAP1 PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; LEUCYL CYSTINYL AMINOPEPTIDASE; LEUCYL-CYSTINYL AMINOPEPTIDASE; PEPTIDE; PLACENTA PROTEIN; PROTEIN PRECURSOR; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME PURIFICATION; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PH; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; ENZYME SPECIFICITY; ENZYMOLOGY; HUMAN; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; MOLECULAR GENETICS; PEPTIDE SYNTHESIS;

AMINO ACID SEQUENCE; AMINOPEPTIDASES; ANTIGEN PRESENTATION; ANTIGENS; CELL LINE; CYSTINYL AMINOPEPTIDASE; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTRACELLULAR FLUID; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PEPTIDES; PREGNANCY PROTEINS; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 77956419148     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902502     Document Type: Article

References (53)

1. Rammensee, H. G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11: 213-244.
2. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
3. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17: 739-779.
4. Cascio, P., C. Hilton, A. F. Kisselev, K. L. Rock, and A. L. Goldberg. 2001. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20: 2357-2366.
5. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651.
6. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
7. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176.
8. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
9. York, I. A., M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock. 2006. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103: 9202-9207.
10. Hammer, G. E., F. Gonzalez, E. James, H. Nolla, and N. Shastri. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8: 101-108.
11. Evnouchidou, I., F. Momburg, A. Papakyriakou, A. Chroni, L. Leondiadis, S. C. Chang, A. L. Goldberg, and E. Stratikos. 2008. The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS ONE 3: e3658.
12. Yan, J., V. V. Parekh, Y. Mendez-Fernandez, D. Olivares- Villagómez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer. 2006. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J. Exp. Med. 203: 647-659.
13. Hammer, G. E., F. Gonzalez, M. Champsaur, D. Cado, and N. Shastri. 2006. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7: 103-112.
14. Firat, E., L. Saveanu, P. Aichele, P. Staeheli, J. Huai, S. Gaedicke, A. Nil, G. Besin, B. Kanzler, P. van Endert, and G. Niedermann. 2007. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178: 2241-2248.
15. Chang, S. C., F. Momburg, N. Bhutani, and A. L. Goldberg. 2005. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proc. Natl. Acad. Sci. USA 102: 17107-17112.
16. Blanchard, N., T. Kanaseki, H. Escobar, F. Delebecque, N. A. Nagarajan, E. Reyes-Vargas, D. K. Crockett, D. H. Raulet, J. C. Delgado, and N. Shastri. 2010. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J. Immunol. 184: 3033-3042.
17. Saveanu, L., O. Carroll, V. Lindo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697.
18. Tsujimoto, M., and A. Hattori. 2005. The oxytocinase subfamily of M1 aminopeptidases. Biochim. Biophys. Acta 1751: 9-18.
19. Tsujimoto, M., Y. Goto, M. Maruyama, and A. Hattori. 2008. Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure. Heart Fail. Rev. 13: 285-291.
20. Hattori, A., H. Matsumoto, S. Mizutani, and M. Tsujimoto. 1999. Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase. J. Biochem. 125: 931-938.
21. Wallis, M. G., M. F. Lankford, and S. R. Keller. 2007. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am. J. Physiol. Endocrinol. Metab. 293: E1092-E1102.
22. Keller, S. R. 2003. The insulin-regulated aminopeptidase: a companion and regulator of GLUT4. Front. Biosci. 8: s410-s420.
23. Rogi, T., M. Tsujimoto, H. Nakazato, S. Mizutani, and Y. Tomoda. 1996. Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J. Biol. Chem. 271: 56-61.
24. Liao, H., S. R. Keller, and J. D. Castle. 2006. Insulin-regulated aminopeptidase marks an antigen-stimulated recycling compartment in mast cells. Traffic 7: 155-167.
25. Ikoma, Y., S. Nomura, T. Ito, Y. Katsumata, M. Nakata, K. Iwanaga, M. Okada, F. Kikkawa, K. Tamakoshi, T. Nagasaka, et al. 2003. Interleukin-1beta stimulates placental leucine aminopeptidase/oxytocinase expression in BeWo choriocarcinoma cells. Mol. Hum. Reprod. 9: 103-110.
26. Saveanu, L., O. Carroll, M. Weimershaus, P. Guermonprez, E. Firat, V. Lindo, F. Greer, J. Davoust, R. Kratzer, S. R. Keller, et al. 2009. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325: 213-217.
27. Segura, E., A. L. Albiston, I. P. Wicks, S. Y. Chai, and J. A. Villadangos. 2009. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc. Natl. Acad. Sci. USA 106: 20377-20381.
28. Cech, P., and R. I. Lehrer. 1984. Phagolysosomal pH of human neutrophils. Blood 63: 88-95.
29. Savina, A., and S. Amigorena. 2007. Phagocytosis and antigen presentation in dendritic cells. Immunol. Rev. 219: 143-156.
30. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
31. Hattori, A., K. Kitatani, H. Matsumoto, S. Miyazawa, T. Rogi, N. Tsuruoka, S. Mizutani, Y. Natori, and M. Tsujimoto. 2000. Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J. Biochem. 128: 755-762.
32. Matsumoto, H., T. Rogi, K. Yamashiro, S. Kodama, N. Tsuruoka, A. Hattori, K. Takio, S. Mizutani, and M. Tsujimoto. 2000. Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur. J. Biochem. 267: 46-52.
33. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanović. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
34. Janda, J., P. Schöneberger, M. Skoberne, M. Messerle, H. Rüssmann, and G. Geginat. 2004. Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products. J. Immunol. 173: 5644-5651.
35. Marañón, C., J. F. Desoutter, G. Hoeffel, W. Cohen, D. Hanau, and A. Hosmalin. 2004. Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 101: 6092-6097.
36. Kisselev, A. F., T. N. Akopian, K. M. Woo, and A. L. Goldberg. 1999. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274: 3363-3371.
37. Cascio, P., M. Call, B. M. Petre, T. Walz, and A. L. Goldberg. 2002. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J. 21: 2636-2645.
38. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11: 137-142.
39. Kuon, W., and J. Sieper. 2003. Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis. Rheum. Dis. Clin. North Am. 29: 595-611.
40. Braun, J., and J. Sieper. 2007. Ankylosing spondylitis. Lancet 369: 1379-1390.
41. Krüger, T., O. Schoor, C. Lemmel, B. Kraemer, C. Reichle, J. Dengjel, T. Weinschenk, M. Müller, J. Hennenlotter, A. Stenzl, et al. 2005. Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol. Immunother. 54: 826-836.
42. Samino, Y., D. López, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val. 2006. A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J. Biol. Chem. 281: 6358-6365.
43. López, D., Y. Samino, U. H. Koszinowski, and M. Del Val. 2001. HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J. Immunol. 167: 4238-4244.
44. Reeves, E. P., H. Lu, H. L. Jacobs, C. G. Messina, S. Bolsover, G. Gabella, E. O. Potma, A. Warley, J. Roes, and A. W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297.
45. Jiang, Q., D. A. Griffin, D. F. Barofsky, and J. K. Hurst. 1997. Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem. Res. Toxicol. 10: 1080-1089.
46. Jankowski, A., C. C. Scott, and S. Grinstein. 2002. Determinants of the phagosomal pH in neutrophils. J. Biol. Chem. 277: 6059-6066.
47. Trombetta, E. S., M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403.
48. Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I. C. Moura, A. M. Lennon-Duménil, M. C. Seabra, G. Raposo, and S. Amigorena. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218.
49. Delamarre, L., M. Pack, H. Chang, I. Mellman, and E. S. Trombetta. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307: 1630-1634.
50. Yates, R. M., A. Hermetter, G. A. Taylor, and D. G. Russell. 2007. Macrophage activation downregulates the degradative capacity of the phagosome. Traffic 8: 241-250.
51. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512.
52. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6: 13-23.
53. Hearn, A., I. A. York, and K. L. Rock. 2009. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. J. Immunol. 183: 5526-5536.